Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.45 |
| ▸ | CASP1 | P29466 | 11/20 | 0.41 |
| ▸ | CASP7 | P55210 | 11/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 11/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.41 |
| ▸ | GLA | P06280 | 6/20 | 0.41 |
| ▸ | TSHR | P16473 | 5/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.41 |
| ▸ | PDE7A | Q13946 | 2/20 | 0.41 |
| ▸ | PDE2A | O00408 | 1/20 | 0.41 |
| ▸ | PDE5A | O76074 | 1/20 | 0.41 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5153869 | 1.00 | ALDH1A1 (0.45) | ALDH1A1CASP1CASP7CYP1A2HSD17B10 | |
| SCHEMBL8241131 | 0.86 | CYP1A2 (0.44) | ALDH1A1CASP1CASP7CYP1A2HSD17B10 | |
| SCHEMBL5155109 | 0.84 | CYP1A2 (0.53) | ALDH1A1CASP1CASP7CYP1A2HSD17B10 | |
| SCHEMBL5153441 | 0.84 | CYP1A2 (0.53) | ALDH1A1CASP1CASP7CYP1A2HSD17B10 | |
| SCHEMBL5153425 | 0.84 | CYP1A2 (0.53) | ALDH1A1CASP1CASP7CYP1A2HSD17B10 | |
| SCHEMBL5150142 | 0.73 | ALDH1A1 (0.52) | ALDH1A1CASP1CASP7CYP1A2HSD17B10 | |
| SCHEMBL5150153 | 0.73 | ALDH1A1 (0.54) | ALDH1A1CASP1CASP7CYP1A2HSD17B10 | |
| SCHEMBL5150370 | 0.72 | PDE4B (0.52) | ALDH1A1CASP1CASP7CYP1A2HSD17B10 | |
| SCHEMBL8241059 | 0.70 | CYP1A2 (0.43) | ALDH1A1CASP1CASP7CYP1A2HSD17B10 | |
| SCHEMBL5154014 | 0.70 | CYP1A2 (0.54) | ALDH1A1CASP1CASP7CYP1A2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070225304-A1 | AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES | PHARMACOPEIA DRUG DISCOVERY, INC. (US) | 2007-09-27 | — | — | US | disclosed |
| US-20070225304-A1 | AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES | PHARMACOPEIA DRUG DISCOVERY, INC. (US) | 2007-09-27 | — | — | US | disclosed |
| US-20070225304-A1 | AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES | PHARMACOPEIA DRUG DISCOVERY, INC. (US) | 2007-09-27 | — | — | US | disclosed |
| WO-2007030438-A2 | AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES | PHARMACOPEIA, INC. (US) | 2007-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225304-A1 | AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES | TPMT, ADORA2A, ENTPD5 | ALDH1A1 705/4885CASP1 628/4885CASP7 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.